Exchange Traded Concepts’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,474
Closed -$115K 1466
2025
Q1
$115K Buy
17,474
+9,450
+118% +$73.6K ﹤0.01% 1106
2024
Q4
$69.9K Hold
8,024
﹤0.01% 1194
2024
Q3
$157K Sell
8,024
-1,864
-19% -$37.8K ﹤0.01% 1053
2024
Q2
$204K Sell
9,888
-3,075
-24% -$63.2K 0.01% 875
2024
Q1
$277K Sell
12,963
-1,212
-9% -$23.6K 0.01% 837
2023
Q4
$204K Buy
14,175
+3,594
+34% +$35.3K 0.01% 788
2023
Q3
$96.5K Sell
10,581
-594
-5% -$6.03K ﹤0.01% 909
2023
Q2
$118K Buy
+11,175
New +$132K ﹤0.01% 914

Other funds holding KURA

Exchange Traded Concepts's KURA Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Kura Oncology (KURA) in Q2 2025, closing a stake of 17,474 shares — an estimated $115K sold.

Exchange Traded Concepts first reported a position in KURA in Q2 2023 and held it in 8 quarters. The position peaked at $277K in Q1 2024. 182 funds tracked by Wall St. Rank hold KURA as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Kura Oncology position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 17,474 Kura Oncology shares in Q2 2025, an estimated $115K.
  • Exchange Traded Concepts first reported a position in Kura Oncology in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Kura Oncology position peaked at $277K in Q1 2024.
  • 182 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.